Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status

Journal of Neuro-Oncology

Volumn 106, Issue 1, 2012, Pages 155-160

  Makino, Keishi ^a   Nakamura, Hideo ^a   Hide, Taku Ichiro ^a   Kuratsu, Jun Ichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

MGMT; Primary central nervous system lymphoma; Salvage chemotherapy; Temozolomide

Indexed keywords

METHOTREXATE; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER RELAPSE; CLINICAL ARTICLE; CONSTIPATION; DISEASE COURSE; DNA METHYLATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; GENE; HUMAN; HUMAN TISSUE; LEUKOPENIA; MALE; MGMT GENE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROMOTER REGION; REFRACTORY PERIOD; RETROSPECTIVE STUDY; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; CENTRAL NERVOUS SYSTEM NEOPLASMS; DACARBAZINE; DISEASE-FREE SURVIVAL; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA; MALE; MIDDLE AGED; SALVAGE THERAPY; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 83055194668     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0652-z     Document Type: Article

References (27)

1. LM DeAngelis 1999 Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy J Neurooncol 43 249 257 10563431 10.1023/A:1006258619757 1:STN:280:DC%2BD3c%2FisV2mtw%3D%3D (Pubitemid 29488383)
2. AJ Ferreri M Reni E Villa 2000 Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials Ann Oncol 11 927 937 11038028 10.1023/A:1008376412784 1:STN:280:DC%2BD3cvoslOksg%3D%3D
3. LE Abrey J Yahalom LM DeAngelis 2000 Treatment for primary CNS lymphoma: the next step J Clin Oncol 18 3144 3150 10963643 1:CAS:528:DC%2BD3cXntVCgsbs%3D
4. T Batchelor K Carson A O'Neill SA Grossman J Alavi P New F Hochberg R Priet 2003 Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07 J Clin Oncol 21 1044 1049 12637469 10.1200/JCO.2003.03.036 1:CAS:528:DC%2BD2cXpsVGqsbc%3D (Pubitemid 46594133)
5. M Reni AJ Ferreri 2001 Therapeutic management of refractory or relapsed primary central nervous system lymphomas Ann Hematol 80 Suppl 3 B113 B117 11757691 1:CAS:528:DC%2BD38XksFKl
6. M Reni AJ Ferreri E Villa 1999 Second-line treatment for primary central nervous system lymphoma Br J Cancer 79 530 534 10027325 10.1038/sj.bjc.6690083 1:STN:280:DyaK1M7kvFGksw%3D%3D (Pubitemid 29046231)
7. Reni M, Ferreri AJ (2004) Is withdrawal of consolidation radiotherapy an evidence-based strategy in primary central nervous system lymphomas? J Clin Oncol 22:1165-1167; author reply 1167-1168
8. AJ Ferreri LE Abrey JY Blay B Borisch J Hochman EA Neuwelt J Yahalom E Zucca F Cavalli J Armitage T Batchelor 2003 Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002 J Clin Oncol 21 2407 2414 12805341 10.1200/JCO.2003.01.135 (Pubitemid 46621879)
9. U Herrlinger W Kuker M Platten J Dichgans M Weller 2002 First-line therapy with temozolomide induces regression of primary CNS lymphoma Neurology 58 1573 1574 12034807 1:STN:280:DC%2BD383ptlOltw%3D%3D (Pubitemid 34552977)
10. M Reni W Mason F Zaja J Perry E Franceschi D Bernardi S Dell'Oro C Stelitano M Candela A Abbadessa A Pace R Bordonaro G Latte E Villa AJ Ferreri 2004 Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial Eur J Cancer 40 1682 1688 15251157 10.1016/j.ejca.2004.03.008 1:CAS:528:DC%2BD2cXls1Wntr8%3D (Pubitemid 38902903)
11. K Makino H Nakamura M Kudo H Takeshima J Kuratsu 2007 Complete response to temozolomide treatment in an elderly patient with recurrent primary central nervous system lymphoma-case report Neurol Med Chir (Tokyo) 47 229 232 10.2176/nmc.47.229 (Pubitemid 46827897)
12. M Reni AJ Ferreri C Landoni E Villa 2000 Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma J Natl Cancer Inst 92 575 576 10749917 10.1093/jnci/92.7.575 1:STN:280: DC%2BD3c3hsFSgtQ%3D%3D (Pubitemid 30212321)
13. HM Strik A Spreer H Nagel S Jacob W Jung B Kitze M Bahr 2004 Clinical response following adjuvant temozolomide in a patient with primary cerebral lymphoma Anticancer Res 24 4121 4125 15736462 (Pubitemid 40468717)
14. M Reni F Zaja W Mason J Perry E Mazza M Spina R Bordonaro F Ilariucci M Faedi G Corazzelli P Manno E Franceschi A Pace M Candela A Abbadessa C Stelitano G Latte AJ Ferreri 2007 Temozolomide as salvage treatment in primary brain lymphomas Br J Cancer 96 864 867 17325700 10.1038/sj.bjc.6603660 1:CAS:528:DC%2BD2sXjt1SrsLc%3D (Pubitemid 46452291)
15. ME Hegi AC Diserens T Gorlia MF Hamou N de Tribolet M Weller JM Kros JA Hainfellner W Mason L Mariani JE Bromberg P Hau RO Mirimanoff JG Cairncross RC Janzer R Stupp 2005 MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 997 1003 15758010 10.1056/NEJMoa043331 1:CAS:528:DC%2BD2MXit1Wktro%3D (Pubitemid 40349502)
16. LE Abrey TT Batchelor AJ Ferreri M Gospodarowicz EJ Pulczynski E Zucca JR Smith A Korfel C Soussain LM DeAngelis EA Neuwelt BP O'Neill E Thiel T Shenkier F Graus M van den Bent JF Seymour P Poortmans JO Armitage F Cavalli 2005 Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma J Clin Oncol Off J Am Soc Clin Oncol 23 5034 5043 10.1200/JCO.2005.13.524 (Pubitemid 46224010)
17. Kamiryo T, Tada K, Shiraishi S, Shinojima N, Kochi M, Ushio Y (2004) Correlation between promoter hypermethylation of the O6-methylguanine- deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea-based chemotherapy. Neurosurgery 54:349-357; discussion 357 (Pubitemid 38209403)
18. N Guha-Thakurta D Damek C Pollack FH Hochberg 1999 Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients J Neurooncol 43 259 268 10563432 10.1023/A:1006210703827 1:STN:280:DC%2BD3c%2FisV2mtA%3D%3D (Pubitemid 29488384)
19. SR Plotkin RA Betensky FH Hochberg SA Grossman GJ Lesser LB Nabors B Chon TT Batchelor 2004 Treatment of relapsed central nervous system lymphoma with high-dose methotrexate Clin Cancer Res Off J Am Assoc Cancer Res 10 5643 5646 10.1158/1078-0432.CCR-04-0159 1:CAS:528:DC%2BD2cXntlOqtLg%3D (Pubitemid 39180936)
20. E Arellano-Rodrigo A Lopez-Guillermo EM Bessell B Nomdedeu E Montserrat F Graus 2003 Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma Eur J Haematol 70 219 224 12656744 10.1034/j.1600-0609.2003.00045.x 1:CAS:528:DC%2BD3sXjslSrtrs%3D (Pubitemid 36469758)
21. RH Enting A Demopoulos LM DeAngelis LE Abrey 2004 Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide Neurology 63 901 903 15365145 1:CAS:528:DC%2BD2cXntV2itL0%3D (Pubitemid 39297656)
22. ET Wong R Tishler L Barron JK Wu 2004 Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas Cancer 101 139 145 15221999 10.1002/cncr.20339 1:CAS:528:DC%2BD2cXlvFCmsrs%3D (Pubitemid 38812433)
23. L Fischer E Thiel HA Klasen J Birkmann K Jahnke P Martus A Korfel 2006 Prospective trial on topotecan salvage therapy in primary CNS lymphoma Ann Oncol 17 1141 1145 16603598 10.1093/annonc/mdl070 1:STN:280:DC%2BD28zotVaktA%3D%3D (Pubitemid 43985251)
24. LC Chu CG Eberhart SA Grossman JG Herman 2006 Epigenetic silencing of multiple genes in primary CNS lymphoma Int J Cancer 119 2487 2491 16858686 10.1002/ijc.22124 1:CAS:528:DC%2BD28XhtVylsLjP (Pubitemid 44546976)
25. D Kurzwelly M Glas P Roth E Weimann H Lohner A Waha M Schabet G Reifenberger M Weller U Herrlinger 2010 Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status J Neurooncol 97 389 392 19841864 10.1007/s11060-009-0032-0 1:CAS:528:DC%2BC3cXltFOnsLs%3D
26. J Hiraga T Kinoshita T Ohno N Mori H Ohashi S Fukami A Noda A Ichikawa T Naoe 2006 Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma Int J Hematol 84 248 255 17050200 10.1532/IJH97.06087 1:CAS:528:DC%2BD28Xht1SqsLnL (Pubitemid 44619247)
27. M Esteller G Gaidano SN Goodman V Zagonel D Capello B Botto D Rossi A Gloghini U Vitolo A Carbone SB Baylin JG Herman 2002 Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma J Natl Cancer Inst 94 26 32 11773279 10.1093/jnci/94.1.26 1:CAS:528:DC%2BD38Xit1amt7Y%3D